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Background
Studies have confirmed that the angiopoietin (Ang)-Tie2 signaling pathway is related 
with functional recovery and prognosis after brain injury (Wang et al. 2015; Chittiboina 
Abstract 
Objective: The aim of this study was to investigate the effects of docosahexaenoic 
acid (DHA) on the generation of angiopoietin-2 (Ang-2) by rat brain microvascular 
endothelial cells under an oxygen- and glucose-deprivation environment (OGD), and 
its relationship, if any, with cyclooxygenase 2 (COX-2) expression.
Methods: Annexin V and propidium iodide apoptosis assay was used to detect 
apoptosis. Enzyme linked immunosorbent assay was used to detect Ang-2, vascular 
endothelial growth factor (VEGF), prostaglandin E2 (PGE2), and prostaglandin I2 (PGI2) 
content. Reverse transcription polymerase chain reaction (RT-PCR) was used to detect 
Ang-2 and VEGF mRNA expression. Western blot was used to detect expression of 
COX-2 protein.
Results: DHA reduced the apoptosis rate (P = 0.026) and decreased the secretion of 
Ang-2, VEGF, PGE2, and PGI2 (P = 0.006, P = 0.000, P = 0.002, P = 0.004 respectively). 
The relative expression of Ang2 and Vegf mRNA, as well as COX-2 expression, also 
decreased (P = 0.000, P = 0.005, P = 0.007 respectively). These effects were antago-
nized by GW9662 (peroxisome proliferator-activated receptor-γ antagonist). COX-2 pro-
tein expression levels were positively correlated with Ang2 and Vegf mRNA expression 
levels (γ = 0.69, P = 0.038 and γ = 0.76, P = 0.032, respectively). Ang-2 and VEGF mRNA 
levels were positively correlated with Ang-2 (γ = 0.84, P = 0.012) and VEGF (γ = 0.71, 
P = 0.036) secretion levels respectively.
Conclusion: DHA reduced apoptosis induced by an OGD environment, thus decreas-
ing Ang-2 and VEGF synthesis. This phenomenon was associated with a decrease in 
COX-2 protein expression, PGE2 and PGI2 secretion, and generation regulation via 
intracellular transcriptional pathways.
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et al. 2013; Fischer et al. 2011). Ang-1 is constitutively produced by pericytes and can 
be induced in several perivascular cell types. Ang-2 is released from the Weibel-Palade 
bodies of brain microvascular endothelial cells (BMVEC) in response to hypoxia or 
inflammatory stimuli, and competes with Ang-1 for Tie-2 receptor binding (Oike et al. 
2004). In the early stages of brain injury, Ang-2 expression rapidly increases, whereas 
Ang-1 amounts decrease. The subsequent Ang-1/Ang-2 imbalance leads to impaired 
Tie-2 activation and reduction of Tie-2 auto-phosphorylation (Kawamura et  al. 2014). 
Tie-2 phosphorylation can increase the expression of phosphoinositide 3-kinase (PI3 K)-
Akt signaling pathway proteins, which has been closely linked to cell survival, as well 
as the expression of endothelial composite materials and endothelial cell gap junction 
stabilization (Hill et al. 2014; Yu et al. 2012; Ruan and Kazlauskas 2013). Therefore, dur-
ing early ischemia, the intervention and regulation of the Ang/Tie2 signaling pathway by 
increasing Ang-1 or decreasing Ang-2 levels may be an effective strategy for protecting 
the brain.
Moreover, the mechanistic functioning of Ang-2 on the endothelial cell appears to 
reflect coordinate signaling between Ang-1 abundance, VEGF receptor occupancy and 
signaling, and other signaling systems. Ang1 opposes the VEGF-induced de-differenti-
ation of BMVEC (Shen et al. 2011), but its effects on BMVEC early after ischemia are 
impeded by a rapid release of Ang2. VEGF may play a role in modulating the function of 
Ang-2. Therefore, it is clear that any evaluation of Ang-2/Ang-1 participation in injury 
should also consider how VEGF levels are affected (Lobov et al. 2002). Increasing evi-
dence strongly supports the role of cyclooxygenase-2 (COX-2) and its metabolic product 
prostaglandin (PG) E2 as regulators of angiogenesis. Under hypoxic conditions, Ang-2 
levels have been closely linked to the expression levels of COX-2, PGE2, and PGI2. 
Inhibiting COX-2 or reducing PGE2 and PGI2 expression can significantly downregulate 
Ang-2 (Iniguez et al. 2003; Pichiule et al. 2004).
In the past decade, the health benefits of unsaturated fatty acids, mainly docosapen-
taenoic acid and docosahexaenoic acid (DHA), have attracted increasing research inter-
est. Eicosapentaenoic acid (EPA) and DHA, which belong to the n-3 polyunsaturated 
fatty acid (PUFA) family, are the main components of deep-sea fish oil. Fish oil, a type of 
peroxisome proliferator-activated receptor (PPAR) γ natural ligand, has been reported 
to slow the progress of kidney disease. A diet rich in n-3 PUFAs, like EPA and DHA, has 
been associated with reduced triacylglycerol (TG) levels and pulmonary disease, as well 
as increased anti-inflammatory activity and a decreased risk of cardiovascular disease 
and mortality (Moertl et al. 2011). Moreover, the present study showed that treatment 
with unsaturated fatty acids can exert neuroprotective effects in both acute and chronic 
brain injury (Mills et al. 2011a, b). Although three PPAR receptor subtypes (α, β/δ, γ) are 
involved in the pathophysiology of brain damage, PPAR-γ was the most closely linked 
to brain injury, and is currently the most thoroughly studied receptor (Benedusi et al. 
2012). Anti-apoptotic, anti-inflammatory, and anti-oxidant were the main mechanisms 
of action (Figueroa et al. 2012; Quartu et al. 2012). However, very few studies regard-
ing the relationship between the mechanisms of DHA brain protection and the Ang/
Tie2 signaling pathway are available at the present. Therefore, we hypothesized that 
DHA may decrease Ang-2 expression by activating PPAR-γ and inhibiting COX-2. This 
study investigated the effects and mechanisms of DHA on the generation of Ang-2 in 
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BMVECs under an oxygen- and glucose-deprivation (OGD) environment, providing a 
scientific basis for future clinical application.
Methods
Isolation and culture of BMVECs
Male Sprague–Dawley (SD) rats (2–3 weeks old, 40–60 g) were provided by the Science 
and Technology Laboratory Animal of Huazhong University. BMVECs was isolated, 
purified, and cultured according a previously described method (Abbott et  al. 2012). 
BMVECs was identified by immunocytochemistry using an anti-VIII factor-related anti-
gen antibody. More than 95 % of 3rd generation cells were BMVECs, which were used in 
experiments. This study was carried out in strict accordance with the recommendations 
in the Guide for the Care and Use of Laboratory Animals of the National Institutes of 
Health. The animal use protocol has been reviewed and approved by the Institutional 
Animal Care and Use Committee (IACUC) of the First People’s Hospital of Yichang.
Preparation and organization of OGD models
The cells were divided into groups based on treatment: control group, OGD group, 
OGD + 10 μM DHA group, OGD + 40 μM DHA group, OGD + 10 μM DHA + GW9662 
group, and OGD  +  40  μM DHA  +  GW9662 group. Third generation BMVECs were 
digested into single cell suspensions, cell density was adjusted to 1  ×  105/mL, and 
seeded in 24-well plates (six parallel wells for each set). Cells were then cultured for 24 h 
under 5  % CO2 condition for synchronization. The original culture of OGD and DHA 
pretreatment groups were then replaced with sugar-free, serum-free DMEM culture 
media. At this point, the two concentrations of DHA was added to the DHA pretreat-
ment groups, and 5 μM GW9662 was added to the OGD + 10 μM DHA + GW9662 and 
OGD + 40 μM DHA + GW9662 groups. All cells were then cultured for 1 h and then 
placed into the hypoxic incubator (94 % N2, 5 % CO2, 1 % O2) for 24 h. DMEM media with 
serum, 5 mM/L glucose and 1.25 mM pyruvate was added to the control group, which 
was cultured under 5 % CO2 and 95 % air conditions. After culturing for 24 h, the super-
natants from each group were collected and stored at −20 °C for enzyme linked immuno-
sorbent assay (ELISA) analysis. Ang-2, vascular endothelial growth factor (VEGF), PGE2, 
and PGI2 content in the supernatants were detected using ELISA kits in accordance with 
manufacturer instructions. The cells were harvested and pelleted for reverse transcription 
polymerase chain reaction (RT-PCR) and Western blot.
Apoptosis detection by flow cytometry
Apoptosis detection was performed in accordance with the manufacturer’s instructions 
using the Annexin V & propidium iodide (PI) apoptosis detection kit (Nanjing KGI Biol-
ogy, China). Briefly, 5 μl Annexin V, 5 μl PI, and 500 μl Binding Buffer was added to each 
sample and mixed at room temperature while protected from light. Reaction time was 
5–15 min, and the negative control was normal cells without addition of Annexin V and 
PI. The first positive control was the solvent group with the most obvious apoptosis, with 
only 5 μl Annexin V single standard. The second positive control was the solvent group 
with the most obvious apoptosis, with only 5 μl PI single standard. Detection was per-
formed using flow cytometry.
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ELISA
Specific Ang-2, VEGF, PGE2, and PGI2 ELISA detection kits were purchased from 
Eli Reiter Biotechnology Co. Ltd. (Wuhan, China). Blanks, standard controls, and test 
samples were added to microtiter plates. Blanks, controls, and samples were diluted to 
100 μl. Labeled antibodies and the biotin were co-incubated with the test samples. After 
washing, the avidin HRP-labeled biotin was added to facilitate binding with the immune 
complexes. After several incubation and washing cycles, the unbound conjugate was 
gradually removed. The added substrate reacted and caused a visible color reaction, 
which showed a proportional relationship with the concentrations present in the sam-
ples. The optical density (OD) values of the samples were detected using an automatic 
biochemical analyzer. Standard curves were plotted according to standard OD values, 
and test sample concentrations were calculated from the standard curve.
RT‑PCR
Cells were collected and total RNA was extracted using Trizol (TAKARA, Dalian, 
China) and detected using real-time PCR. The expression of the β-actin gene was used 
as an internal reference control. RT-PCR reaction conditions were established using 
conventional methods. The sequences of the Ang2 primers were: upstream primer, 
5′-AGCCAGTCTCCCTTCCAG-3′, downstream primer, 5′-AGGCAAGCCATTCTCA 
CA-3′, amplicon 123  bp; Vegf primer sequences were: upstream primer, 5′-ATCAAG 
GCCGTCTGTGGT-3′, downstream primer, 5′-GGTTTCGGAGGTCAGTGTT-3′, 
amplicon 287  bp; internal reference β-actin primer sequences: upstream primer, 
5′-CACGATGGAGGGGCCGGACTCATC-3, downstream primer, 5′-TAAAGACCTCT 
ATGCCAACACAGT-3′, amplicon 240 bp. Reaction system: reaction volume of 20 μl, 
containing 4  μl cDNA, 0.4  μl primers. The reaction conditions were 50  °C for 2  min, 
95  °C for 10  min, 40 cycles of 95  °C for 30  s and 60  °C for 30  s. Fluorescence signals 
were collected during the annealing stage, and the results were analyzed using real-time 
quantitative analysis software for the ViiA7 real-time PCR instrument.
Western blot
Appropriate RIPA lysis buffer (Pik Days, Shanghai, China) was used to lyse cells, which 
were then centrifuged to obtain and extract the supernatant. Protein concentrations for 
each sample were then measured, the total protein was sampling for electrophoresis. 
Electric water bath blotting was used to transfer proteins to PVDF membranes (Milli-
pore, Germany). The corresponding anti-blocking solution was used to dilute primary 
antibodies. The membranes were immersed in rabbit anti-mouse COX-2 antibody 
(Santa Cruz, Shanghai, China) incubation media and incubated overnight at 4 °C. PVDF 
membranes were washed thoroughly with TBST 5–6 times, 5 min each. Blocking solu-
tion was used to dilute corresponding HRP-labeled secondary antibodies (Wuhan Boster 
Biological Engineering Co., Ltd., Wuhan, China). Membranes were then immersed in 
secondary antibody incubation media, incubated on a shaking bed at room temperature 
for 2 h. PVDF membranes were then sufficiently washed with TBST for 5-6 times, 5 min 
each. An appropriate amount of ECL substrate solution (Thermo, Shanghai, China) was 
added to each membrane and incubated for several minutes. After fluorescence bands 
were visible, developing and fixing solutions were added in turn. Each experiment was 
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repeated three times. The densitometry of the targeted protein COX-2 and reference 
bands were analyzed using a biological electrophoresis image analysis system, and the 
relative expression of the targeted protein was obtained by comparing the densitometry 
of the targeted bands and internal references for the same sample.
Statistical analysis
SPSS v.13.0 software analysis was used for data analysis. Data were expressed as 
mean  ±  standard deviation (x  ±  s). One-way ANOVA (multiple comparison among 




Apoptosis in BMVECs of the OGD, OGD  +  10  μM DHA, OGD  +  40  μM DHA, 
OGD  +  10  μM DHA  +  GW9662, and OGD  +  40  μM DHA  +  GW9662 groups 
increased significantly compared with the control group (P  <  0.01). Apoptosis of the 
OGD +  10  μM DHA group and OGD +  40  μM DHA groups was significantly lower 
compared to the OGD group (P  <  0.05). The OGD  +  10  μM DHA  +  GW9662 and 
OGD + 40 μM DHA + GW9662 group showed no significant differences in apoptosis. 
The OGD + 40 μM DHA group had significant differences in apoptosis compared with 
the OGD + 10 μM DHA group (P < 0.05; Fig. 1).
Secretion of Ang‑2, VEGF, PGE2, and PGI2
Compared with the normal control group, Ang-2, VEGF, PGE2, and PGI2 secretion levels 
of the OGD, OGD +10 μM DHA, OGD + 40 μM DHA, OGD + 10 μM DHA GW9662, 
and OGD +  40  μM DHA +  GW9662 groups were significantly increased (P  <  0.01). 
Compared with the OGD group, Ang-2, VEGF, PGE2, and PGI2 secretion of the 
OGD + 10 μM DHA and OGD + 40 μM DHA groups decreased significantly (P < 0.01), 
while the OGD + 10 μM DHA + GW9662 and OGD + 40 μM DHA + GW9662 groups 
showed no significant difference. Compared with the OGD  +  10  μM DHA group, 
OGD + 40 μM DHA group had a significant difference (P < 0.01; Fig. 2A–D).
Ang2 and Vegf mRNA expression
2−ΔΔCt quantitative analysis was used. Ang2 and Vegf mRNA expression in OGD, 
OGD +  10  μM DHA, OGD  +  40  μM DHA, OGD  +  10  μM DHA +  GW9662, and 
OGD + 40 μM DHA + GW9662 pretreatment groups were 10.8-, 6.4-, 3.9-, 9.6-, 9.4-fold 
greater (P < 0.01) and 3.1-, 2.3-, 1.7-, 2.9-, 2.8-times greater (P < 0.01) than the control 
group respectively. Compared with the OGD group, Ang2 and Vegf mRNA expression 
in the 10  μM DHA and 40  μM DHA pretreatment groups was significantly reduced, 
while the OGD + 10 μM DHA + GW9662 and OGD + 40 μM DHA + GW9662 group 
showed no significant difference (P > 0.05). Compared with the OGD +  10 μM DHA 
group, the OGD + 40 μM DHA group had significant difference (P < 0.01; Fig. 3).
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Expression of COX‑2 protein
Western blotting assay showed that, compared with the control group, COX-2 protein 
expression in the OGD, OGD +  10  μM DHA, OGD +  40  μM DHA, OGD +  10  μM 
DHA + GW9662, and OGD + 40 μM DHA + GW9662 groups significantly increased 
(P < 0.01). Compared with the OGD group, COX-2 expression of the 10 μM DHA and 
40 μM DHA pretreatment groups decreased significantly (P < 0.01), while OGD + 10 μM 
DHA + GW9662 and OGD + 40 μM DHA + GW9662 groups showed no significant 
difference. The COX-2 protein expression of the 40 μM DHA pretreatment group was 
significantly lower than the 10 μM DHA pretreatment group (P < 0.01; Fig. 4).
Fig. 1 A, B, C, D, E, F Scatter plot of apoptosis. A control group, B OGD, C OGD + 10 μM DHA, D OGD + 40 
μM DHA, E OGD + 10 μM DHA + GW9662, F OGD + 40 μM DHA + GW9662, G histogram of apoptosis. 1 
control group, 2 OGD, 3 OGD + 10 μM DHA, 4 OGD + 40 μM DHA, 5 OGD + 10 μM DHA + GW9662, 6 OGD 
+ 40 μM DHA + GW9662. Compared with the control group, aP < 0.01; compared with OGD group, bP < 0.01; 
compared with 10 μM DHA pretreated group, cP < 0.01
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Correlation between COX‑2 protein expression with Ang2 and Vegf mRNA
COX-2 protein expression was positively correlated with Ang2 and Vegf mRNA levels; 
the correlation coefficients were 0.69 and 0.76 (P  <  0.05) respectively. Ang2 and Vegf 
mRNA and Ang2 and VEGF secretion levels were positively correlated, with the correla-
tion coefficients being 0.84 and 0.71 (P < 0.05) respectively.
Discussion
It has been demonstrated extensively in the literature that Ang-2 levels were elevated in 
the cerebrospinal fluid of patients with brain damage, whereas Ang-1 levels were reduced. 
Alterations in the cerebrospinal fluid levels of these markers may provide a new clinical 
index to predict disease severity, or represent different mechanisms of brain injury (Kuro-
saka et  al. 2010; Chen et  al. 2010). The interaction between Ang-1 and Ang-2 allowed 
researchers to re-examine how to perform angiopoietin system targeting therapy for 
patients with severe brain injury to improve blood–brain barrier and reduce brain edema. 
For some chronic diseases such as diabetes, the use of DHA can effectively reduce plasma 
levels of Ang-2. This mechanism may have some beneficial effects in the treatment of 
ischemic brain injury (Nomura et  al. 2009). Our results showed that DHA can reduce 
apoptosis of BMVECs and generation of Ang-2 in an in vitro hypoxic environment.
Fig. 2 A Ang2 secretion of each group. 1 control group, 2 OGD, 3 OGD + 10 μM DHA, 4 OGD + 40 μM 
DHA, 5 OGD + 10 μM DHA + GW9662, 6 OGD + 40 μM DHA + GW9662. Compared with the control 
group, aP < 0.01; compared with OGD group, bP < 0.01; compared with the 10 μM DHA pretreated group, 
cP < 0.01. B VEGF secretion in each group. 1 control group, 2 OGD, 3 OGD + 10 μM DHA, 4 OGD + 40 μM 
DHA, 5 OGD + 10 μM DHA + GW9662, 6 OGD + 40 μM DHA + GW9662. Compared with the control 
group, aP < 0.01; compared with OGD group, bP < 0.01; compared with the 10 μM DHA pretreated group, 
cP < 0.01. C PGE2 secretion of each group. 1 control group, 2 OGD, 3 OGD + 10 μM DHA, 4 OGD + 40 μM 
DHA, 5 OGD + 10 μM DHA + GW9662, 6 OGD + 40 μM DHA + GW9662. Compared with the control group, 
aP < 0.01; compared with OGD group, bP < 0.01; compared with the 10 μM DHA pretreated group, cP < 0.01. 
D PGI2 secretion levels in each group. 1 control group, 2 OGD, 3 OGD + 10 μM DHA, 4 OGD + 40 μM DHA, 
5 OGD + 10 μM DHA + GW9662, 6 OGD + 40 μM DHA + GW9662. Compared with the control group, 
aP < 0.01; compared with OGD group, bP < 0.01; compared with the 10 μM DHA pretreated group, cP < 0.01
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Our results showed that Ang-2 and VEGF protein expression levels in BMVECs under 
an OGD environment were significantly increased, which was consistent with previ-
ous studies (Abdulmalek et  al. 2001). In addition to being markers reflecting second-
ary injury, Ang-2 has been shown to cause blood–brain barrier damage and increased 
endothelial cell apoptosis. The results showed that the injection of Ang-2 in the cerebral 
cortex can induce significant blood–brain barrier damage in the region surrounding 
the injection area, as well as leptomeningeal vascular endothelial cell apoptosis. Injec-
tion of 400  ng Ang-2 has been shown to produce a relatively large area of extravasa-
tion horseradish peroxidase. The study also showed that blood brain barrier damage 
Fig. 3 A RT-PCR strip chart for Ang2 and VEGF. 1 control group, 2 OGD, 3 OGD + 10 μM DHA, 4 OGD + 40 μM 
DHA, 5 OGD + 10 μM DHA + GW9662, 6 OGD + 40 μM DHA + GW9662. B RT-PCR histogram for Ang2. 
1 control group, 2 OGD, 3 OGD + 10 μM DHA, 4 OGD + 40 μM DHA, 5 OGD + 10 μM DHA + GW9662, 6 
OGD + 40 μM DHA + GW9662. Compared with OGD group, bP < 0.01; compared with the 10 μM DHA 
pretreated group, cP < 0.01. C RT-PCR histogram for VEGF. 1 control group, 2 OGD, 3 OGD + 10 μM DHA, 4 
OGD + 40 μM DHA, 5 OGD + 10 μM DHA + GW9662, 6 OGD + 40 μM DHA + GW9662. Compared with OGD 
group, bP < 0.01; compared with the 10 μM DHA pretreated group, cP < 0.01
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in the early stages after injury was related with the rapid increase and mobilization of 
Ang-2 expression and the reduction of Ang-1 levels, the latter being structurally formed 
and expressed in endothelial cells. Ang-2 expression increases occurred in the first few 
hours after damage. In the late stages, Ang-2 and activated caspase-3 expression was 
co-localized in endothelial cells, suggesting that Ang-2 played a role in endogenous-and 
exogenous-triggered endothelial cell apoptosis (Nag et al. 2011). Our results showed that 
DHA can reduce apoptosis of BMVECs in an in vitro hypoxic environment, which may 
be related to its role in reducing Ang-2 generation.
Ang-2 expression level increases under an anoxic environment has been shown to be 
related to hypoxia-inducible factor 1 (HIF-1), as well as the expression of cyclooxygenase 
2 (COX-2) and concomitant PGE2 and PGI2 secretion (Pichiule et al. 2004; Meijerink 
et al. 2015). COX-2 inhibitors can be used to reduce hypoxia-induced Ang-2 levels, and 
was closely related with the reduction of PGE2 and PGI2 levels. These studies confirmed 
that the formation of COX-2-dependent prostaglandins played a more important role 
in regulating the generation of hypoxia-induced Ang-2. In a colon tumor cell model, it 
was found that high levels of COX-2 expression promoted the synthesis of angiogenic 
factors such as VEGF and Ang-2 (Yoshid-Amano et al. 2003). In vivo studies have shown 
that PGE(2)-stimulates VEGF expression in rat gastric microvascular endothelial cells 
(RGMEC) via transactivation of JNK1 by ERK2 (Pai et al. 2001). Our results indicated 
that DHA pretreatment reduced COX-2 expression and prostaglandin production in a 
dose-dependent manner. COX-2 expression was found to be positively correlated with 
PGE2 and PGI2 secretion levels. In vivo studies have also shown that DHA can reduce 
oxidative stress and cerebral ischemia–reperfusion injury by reducing COX-2 expression 
(Quartu et al. 2012).
Our experiments have also found that DHA pretreatment can reduce the transcrip-
tion levels of Ang2 and Vegf mRNA. Correlation analysis showed that COX-2 expression 
Fig. 4 A Western blot strip chart for COX2. 1 control group, 2 OGD, 3 OGD + 10 μM DHA, 4 OGD + 40 μM 
DHA, 5 OGD + 10 μM DHA + GW9662, 6 OGD + 40 μM DHA + GW9662. B Western blot histogram for COX2. 
1 control group, 2 OGD, 3 OGD + 10 μM DHA, 4 OGD + 40 μM DHA, 5 OGD + 10 μM DHA + GW9662, 6 OGD 
+ 40 μM DHA + GW9662. Compared with the control group, aP < 0.01; compared with OGD group, bP < 0.01; 
compared with the 10 μM DHA pretreated group, cP < 0.01
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was positively correlated with Ang2 and VEGF mRNA levels, and Ang2 and Vegf mRNA 
levels were positively correlated with Ang-2 and VEGF secretion levels respectively. 
These results indicated that COX-2 exerted transcriptional regulatory effects on Ang-2 
and VEGF in cells via the prostaglandin pathway. Recent studies have found that DHEA 
(one polyunsaturated fatty acid) can inhibit the production of macrophage inflammatory 
cytokines through COX-2-mediated transcriptional regulation.
DHA are essential highly unsaturated fatty acids in the body, which regulate a variety 
of gene transcription targets through binding with PPARs and others (Randy and Guoy-
ing 2007). PPARs are members of the nuclear receptor superfamily, which are actively 
involved in immune regulation by regulating membrane lipid composition, cell prolifera-
tion, sensitivity to apoptosis, energy homeostasis, and various inflammatory transcrip-
tion factors. Although all three PPAR subtypes of are involved in the pathophysiology of 
brain damage, PPAR-γ has been established as the most closely related with brain injury, 
and is the most thoroughly studied receptor subtype (Benedusi et al. 2012). In the pre-
sent study, it was found that the PPAR-γ inhibitor GW9662 can inhibit the protective 
effects of DHA, further confirming that PPAR-γ is closely related to brain damage.
In this study, the culture media used to treat BMVECs was a sugar-free and serum-
free DMEM culture media. BMVECs were placed in a three-gas incubator to create a 
94 % N2: 5 % CO2: 1 % O2 hypoxic environment and cultured for 24 h to simulate in vivo 
ischemia. This model has been used relatively infrequently compared with the hypoxia/
reoxygenation model used in most previous studies, and may induce less damage to cells 
compared with the hypoxic/reoxygenation model.
The following deficiencies may exist in the present study. First, the result that DHA 
can reduce Ang-2 expression and generation cannot be fully confirmed as the sole medi-
ator of the protective effect, and a specific inhibitor of Ang-2 was not used as a control. 
Therefore, DHA-mediated suppression of Ang-2 as a protective mechanism may be just 
an indirect speculation. Second, the present study only used a model of hypoxia, which 
was also quite different from other hypoxia/reoxygenation models. In addition, in vitro 
and in vivo models are very different. As such, this phenomenon, as well as the relation-
ship between DHA mechanisms and the angiopoietin pathway regarding cytoprotection, 
need to be confirmed in future studies performed using in vivo models.
In summary, DHA treatment induced decreases in Ang-2 and VEGF levels under an 
OGD environment, which may be associated with decreased COX-2 protein expression 
and PGE2 and PGI2 secretion, as well as the generation regulation by intracellular tran-
scriptional pathways. These findings may have wide therapeutic applications regarding 
the treatment of acute cerebral ischemic damage and post-secondary damage, and pro-
vides some scientific basis for future clinical application.
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